RDD is devoted to developing specific medications and delivery systems to treat disorders of the anorectal area and lower digestive tract. Special formulation and delivery/application techniques are essential for addressing the wide range of anatomy and physiology in this challenging area. The anorectal region presents distinct physiological obstacles, such as high temperature and humidity, frequent passage of stools that abrade the surface, and varying absorptive capacity of different membranes.
Rdd Pharma
Headquarters
United States of America